-+ 0.00%
-+ 0.00%
-+ 0.00%

Molecular Templates' Board Of Directors Approved The Liquidation And Wind-up Of The Company, The Company Also Plans To Wind Down The Phase 1 Studies For MT-6402 and MT-8421 But To Continue FDA Discussions For MT-0169 For Autoimmune Indications-Filing

Benzinga·10/14/2024 08:44:14
Listen to the news

The Board approved a reduction in force of substantially all of the Company's employees